Jennifer L.H. Johnson

Jennifer L.H. Johnson has extensive work experience in the pharmaceutical and medical device industry. Jennifer L.H. is currently serving as the Chief Scientific Officer at NuvOx Pharma since 2022. Prior to this role, they worked as the Manager of Regulatory Affairs for Companion Diagnostics at Ventana Medical Systems starting from 2021. From 2020 to 2021, they held the position of Director of CMC at Microbion Corporation.

Jennifer's earlier experience includes serving as the Director of Regulatory Affairs, Quality Assurance, and Product Compliance at Thayer Medical Corporation from 2018 to 2020. During their tenure at Thayer Medical Corporation, they also held the positions of Director of R&D and Regulatory Affairs from 2017 to 2020 and Director of R&D from 2013 to 2018. In these roles, they played a key role in regulatory submissions and the upgrade of the Quality Management System.

Before joining Thayer Medical Corporation, Jennifer worked as the Chief Operating Officer at NuvOx Pharma from 2009 to 2013. Prior to that, they held the position of Scientist II at Oncothyreon, Inc. from 2007 to 2009, and Scientist I at ImaRx Therapeutics from 2005 to 2007.

Jennifer L.H. Johnson brings a wealth of experience in scientific oversight, regulatory affairs, and product development to their current role as Chief Scientific Officer at NuvOx Pharma.

Jennifer L.H. Johnson completed their education with a Bachelor of Arts (B.A.) degree in Psychology from The University of Arizona, where they studied from 1993 to 1996. Following that, they pursued their Doctor of Philosophy (Ph.D.) in Pharmaceutics and Drug Design at the same university, from 1999 to 2005.